---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-23-000062"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T05:31:16.720272+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# PetMed Express annual meeting results: all director nominees elected, advisory votes approved

## Summary
- All five director nominees elected: Leslie Campbell, Sandra Campos, Gian Fulgoni, Mathew Hulett, Diana Purcel (11.4M-12.4M votes for each).
- Advisory vote on executive compensation approved (11.18M for, 1.04M against, 0.48M abstain).
- Shareholders recommended one-year frequency for future say-on-pay votes (12.33M for 1-year, 4.28M broker non-votes).
- Ratification of RMS US LLP as auditor for fiscal 2024 passed with 16.76M for, 0.15M against.

## SEC filing metadata
- accession: 0001040130-23-000062
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000062/0001040130-23-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000062/pets-20230803.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-23-000062
- JSON: https://secwatch.observer/filing/0001040130-23-000062.json
- Plain text: https://secwatch.observer/filing/0001040130-23-000062.txt

## Key facts
- Shareholder Votes
  PETMED EXPRESS INC shareholders approved Advisory vote on compensation of named executive officers at the 2023-08-03 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-08-03
  source text: Proposal 2 - The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers named in the Proxy Statement by the following final voting results:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000062/0001040130-23-000062-index.htm
- Shareholder Votes
  PETMED EXPRESS INC shareholders approved Election of Directors at the 2023-08-03 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-08-03
  source text: Proposal 1 - The five director nominees proposed by the Company’s Board of Directors (“Board”) were elected to serve as members of the Board until the next annual meeting of shareholders and until their respective successors have been duly elected and qualified by the following final voting results:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000062/0001040130-23-000062-index.htm
- Shareholder Votes
  PETMED EXPRESS INC shareholders approved Ratification of appointment of RMS US LLP as independent registered public accounting firm for fiscal year 2024 at the 2023-08-03 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-08-03
  source text: Proposal 4 - The Company’s shareholders ratified the appointment of RMS US LLP as the Company’s independent registered public accounting firm for fiscal year 2024 by the following final voting results:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000062/0001040130-23-000062-index.htm
- Shareholder Votes
  PETMED EXPRESS INC shareholders approved Advisory vote on frequency of future advisory votes on named executive officer compensation at the 2023-08-03 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-08-03
  source text: Proposal 3 - The Company’s shareholders recommended, on an advisory basis, a frequency of every year for future advisory votes on named executive officer compensation by the following final voting results:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000062/0001040130-23-000062-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.